NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer research"
DOI: 10.1158/0008-5472.can-22-1903
Abstract: Radiotherapy is one of the primary treatments of head and neck squamous cell carcinoma (HNSCC), which has a high risk of locoregional failure (LRF). Presently, there is no reliable predictive biomarker of radioresistance in HNSCC.… read more here.
Keywords: head neck; nfe2l2 mutations; intratumoral myeloid; cancer ... See more keywords